DENTSPLY SIRONA INC (XRAY) Forecast, Price Target & Analyst Ratings

NASDAQ:XRAY • US24906P1093

Current stock price

12.17 USD
-0.14 (-1.14%)
At close:
12.16 USD
-0.01 (-0.08%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DENTSPLY SIRONA INC (XRAY).

Forecast Snapshot

Consensus Price Target

Price Target
$14.71
+ 20.88% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
$0.30
Revenue Estimate
866.28M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
70.48%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$14.71
Upside
+ 20.88%
From current price of $12.17 to mean target of $14.71, Based on 21 analyst forecasts
Low
$12.12
Median
$14.28
High
$18.90

Price Target Revisions

1 Month
11.25%
3 Months
14.40%

Price Target Summary

21 Wall Street analysts provided a forecast for the next 12 months for XRAY. The average price target is 14.71 USD. This implies a price increase of 20.88% is expected in the next year compared to the current price of 12.17.
The average price target has been revised upward by 14.4% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

XRAY Current Analyst RatingXRAY Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

XRAY Historical Analyst RatingsXRAY Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
70.48%
XRAY was analyzed by 21 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about XRAY.
In the previous month the buy percentage consensus was at a similar level.
XRAY was analyzed by 21 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-15CitigroupInitiate Sell
2026-03-02Barrington ResearchMaintains Outperform -> Outperform
2026-03-02MizuhoMaintains Neutral -> Neutral
2026-02-27Wells FargoMaintains Equal-Weight -> Equal-Weight
2026-02-27Evercore ISI GroupMaintains In-Line -> In-Line
2026-02-27BairdMaintains Neutral -> Neutral
2026-02-19B of A SecuritiesUpgrade Neutral -> Buy
2026-02-03UBSMaintains Buy -> Buy
2026-01-20MizuhoMaintains Neutral -> Neutral
2026-01-05Barrington ResearchMaintains Outperform -> Outperform
2025-12-16Barrington ResearchMaintains Outperform -> Outperform
2025-12-16BairdMaintains Neutral -> Neutral
2025-12-09BarclaysInitiate Underweight
2025-11-10Barrington ResearchMaintains Outperform -> Outperform
2025-11-07William BlairDowngrade Outperform -> Market Perform
2025-11-07Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-11-07JP MorganMaintains Neutral -> Neutral
2025-10-29Barrington ResearchMaintains Outperform -> Outperform
2025-10-28UBSMaintains Buy -> Buy
2025-10-08Evercore ISI GroupMaintains In-Line -> In-Line
2025-09-26NeedhamReiterate Hold -> Hold
2025-08-08Barrington ResearchMaintains Outperform -> Outperform
2025-08-08UBSMaintains Buy -> Buy
2025-08-08StifelMaintains Hold -> Hold
2025-08-08Wells FargoMaintains Equal-Weight -> Equal-Weight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
$0.30
Revenue Estimate
866.28M
Revenue Q2Q
-1.45%
EPS Q2Q
-30.72%
Number of Analysts
17

Next Earnings Revisions

Revenue (1 Month)
0.31%
Revenue (3 Months)
-5.63%
EPS (1 Month)
-4.57%
EPS (3 Months)
-25.08%

Next Earnings Summary

XRAY is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is 0.3 USD and the consensus revenue estimate is 866.28M USD.
The next earnings revenue estimate has been revised downward by 5.63% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2029

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
XRAY revenue by date.XRAY revenue by date.
3.965B
1.10%		3.793B
-4.34%		3.68B
-2.98%		3.649B
-0.84%		3.724B
2.06%		3.835B
2.98%		3.916B
2.11%
EBITDA
YoY % growth
XRAY ebitda by date.XRAY ebitda by date.
639M
-7.66%		579M
-9.39%		605M
4.49%		619.16M
2.34%		647.61M
4.59%		693.92M
7.15%		777.24M
12.01%
EBIT
YoY % growth
XRAY ebit by date.XRAY ebit by date.
296M
-18.68%		230M
-22.30%		253M
10.00%		474M
87.35%		500.52M
5.59%		536.32M
7.15%		506.94M
-5.48%
Operating Margin
XRAY operating margin by date.XRAY operating margin by date.
7.47%6.06%6.88%12.99%13.44%13.98%12.95%
EPS
YoY % growth
XRAY eps by date.XRAY eps by date.
1.83
-12.02%		1.67
-8.74%		1.59
-4.79%		1.46
-8.16%		1.59
8.55%		1.78
12.02%		1.87
5.31%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		0.30
-30.72%		0.39
-25.58%		0.37
0.51%		0.40
49.98%		0.34
15.43%		0.42
8.03%		0.39
3.78%		0.44
8.38%		0.35
0.85%		0.41
-2.41%		0.44
13.64%		0.58
32.48%
Revenue
Q2Q % growth		866.28M
-1.45%		917.5M
-1.98%		905.66M
0.18%		977.56M
1.72%		882.29M
1.85%		933.2M
1.71%		918.01M
1.36%		1.001B
2.40%		919.98M
4.27%		972.43M
4.20%		958.35M
4.39%		1.029B
2.80%
EBITDA
Q2Q % growth		136.1M
-10.46%		160.32M
-42.33%		153.65M
-50.11%		164.04M
-55.90%		143.66M
5.55%		163.31M
1.87%		163.22M
6.23%		188.8M
15.09%		144.08M
0.29%		165.29M
1.21%		172.02M
5.39%		214.61M
13.67%
EBIT
Q2Q % growth		100.96M
38.30%		124.28M
11.96%		117.7M
140.20%		126.79M
533.95%		105.58M
4.58%		124.09M
-0.15%		123.99M
5.34%		147.62M
16.43%		111.96M
6.04%		128M
3.15%		135.85M
9.57%		171.54M
16.20%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

XRAY Yearly Revenue VS EstimatesXRAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
XRAY Yearly EPS VS EstimatesXRAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2 2.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
3.75%
EPS Next 5 Year
4.14%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
1.05%
Revenue Next 5 Year
1.31%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
9.39%
EBIT Next 5 Year
10.04%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

DENTSPLY SIRONA INC / XRAY Forecast FAQ

What is the average price target for DENTSPLY SIRONA INC (XRAY) stock?

21 analysts have analysed XRAY and the average price target is 14.71 USD. This implies a price increase of 20.88% is expected in the next year compared to the current price of 12.17.

What is the next earnings date for XRAY stock?

DENTSPLY SIRONA INC (XRAY) will report earnings on 2026-05-13, before the market open.

Can you provide the consensus estimates for DENTSPLY SIRONA INC next earnings?

The consensus EPS estimate for the next earnings of DENTSPLY SIRONA INC (XRAY) is 0.3 USD and the consensus revenue estimate is 866.28M USD.

Can you provide the consensus rating for DENTSPLY SIRONA INC stock?

The consensus rating for DENTSPLY SIRONA INC (XRAY) is 70.4762 / 100 . This indicates that analysts generally have a positive outlook on the stock.